Clusters of high-risk, low-risk, and temporal trends of breast and cervical cancer-related mortality in S?o Paulo, Brazil, during 20 0 0-2016

被引:1
|
作者
Bermudi, P. M. M. [1 ]
Pellini, A. C. G. [2 ,3 ]
Diniz, C. S. G. [1 ]
Ribeiro, A. G. [4 ]
de Aguiar, B. S. [5 ]
Failla, M. A. [6 ]
Neto, F. Chiaravalloti [1 ]
机构
[1] Univ Sao Paulo, Sch Publ Hlth, Sao Paulo, Brazil
[2] Nove Julho Univ, UNINOVE, Sao Paulo, Brazil
[3] Sao Caetano Municipal Univ Sao Caetano, Sao Caetano do Sul, Brazil
[4] Barretos Canc Hosp, Educ & Res Inst, Barretos, SP, Brazil
[5] Municipal Hlth Dept Sao Paulo Coordinat Epidemiol, Sao Paulo, SP, Brazil
[6] Ctr Geoproc & Socioenvironmental Informat GISA, Municipal Hlth Dept Sao Paulo, Coordinat Epidemiol & Informat CEInfo, Sao Paulo, Brazil
基金
巴西圣保罗研究基金会;
关键词
Breast neoplasms; Uterine cervical neoplasms; Cluster analysis; Social conditions; HEALTH-CARE; ACCESS;
D O I
10.1016/j.annepidem.2022.12.009
中图分类号
R1 [预防医学、卫生学];
学科分类号
1004 ; 120402 ;
摘要
Purpose: Studying breast and cervical cancers in space and time and verifying divergences of different territorially established socioeconomic profiles. Methods: Ecological study using spatial scanning (with socioeconomic characterization), space-time, and spatial variation of temporal trends, in order to identify significant clusters of high- and low-risk or temporal trends, of deaths from breast cancer and cervical cancer, in the city of Sao Paulo, Brazil, during 20 0 0-2016. Results: High-risk spatial clusters were identified in the central areas, and low-risk clusters were identified in the peripheral areas, which were associated with better and worse socioeconomic conditions, respectively. As for cervical cancer, the pattern was the opposite. High-risk space-time clusters occurred in the early years of the study, whereas low-risk clusters occurred in the most recent years. For breast cancer, the central areas showed a temporal trend of decreasing mortality and the peripheral areas showed an increasing trend. While for cervical cancer, in general, the temporal trend was for the identified clusters to fall. Conclusions: It is expected that this study will provide insights for the formulation of public policies to implement prevention and control measures, in order to reduce mortality and inequalities related to breast and cervical cancers.
引用
收藏
页码:61 / 67
页数:7
相关论文
共 4 条
  • [1] Reducing chemotherapy use in clinically high-risk, genomically low-risk pN0 and pN1 early breast cancer patients: five-year data from the prospective, randomised phase 3 West German Study Group (WSG) PlanB trial
    Nitz, Ulrike
    Gluz, Oleg
    Christgen, Matthias
    Kates, Ronald E.
    Clemens, Michael
    Malter, Wolfram
    Nuding, Benno
    Aktas, Bahriye
    Kuemmel, Sherko
    Reimer, Toralf
    Stefek, Andrea
    Lorenz-Salehi, Fatemeh
    Krabisch, Petra
    Just, Marianne
    Augustin, Doris
    Liedtke, Cornelia
    Chao, Calvin
    Shak, Steven
    Wuerstlein, Rachel
    Kreipe, Hans H.
    Harbeck, Nadia
    BREAST CANCER RESEARCH AND TREATMENT, 2017, 165 (03) : 573 - 583
  • [2] Reducing chemotherapy use in clinically high-risk, genomically low-risk pN0 and pN1 early breast cancer patients: five-year data from the prospective, randomised phase 3 West German Study Group (WSG) PlanB trial
    Ulrike Nitz
    Oleg Gluz
    Matthias Christgen
    Ronald E. Kates
    Michael Clemens
    Wolfram Malter
    Benno Nuding
    Bahriye Aktas
    Sherko Kuemmel
    Toralf Reimer
    Andrea Stefek
    Fatemeh Lorenz-Salehi
    Petra Krabisch
    Marianne Just
    Doris Augustin
    Cornelia Liedtke
    Calvin Chao
    Steven Shak
    Rachel Wuerstlein
    Hans H. Kreipe
    Nadia Harbeck
    Breast Cancer Research and Treatment, 2017, 165 : 573 - 583
  • [3] Correction to: Reducing chemotherapy use in clinically high-risk, genomically low-risk pN0 and pN1 early breast cancer patients: five-year data from the prospective, randomised phase 3 West German Study Group (WSG) PlanB trial
    Ulrike Nitz
    Oleg Gluz
    Matthias Christgen
    Ronald E. Kates
    Michael Clemens
    Wolfram Malter
    Benno Nuding
    Bahriye Aktas
    Sherko Kuemmel
    Toralf Reimer
    Andrea Stefek
    Fatemeh Lorenz-Salehi
    Petra Krabisch
    Marianne Just
    Doris Augustin
    Cornelia Liedtke
    Calvin Chao
    Steven Shak
    Rachel Wuerstlein
    Hans H. Kreipe
    Nadia Harbeck
    Breast Cancer Research and Treatment, 2019, 175 : 265 - 266
  • [4] Reducing chemotherapy use in clinically high-risk, genomically low-risk pN0 and pN1 early breast cancer patients: five-year data from the prospective, randomised phase 3 West German Study Group (WSG) PlanB trial (vol 165, pg 573, 2017)
    Nitz, Ulrike
    Gluz, Oleg
    Christgen, Matthias
    Kates, Ronald E.
    Clemens, Michael
    Malter, Wolfram
    Nuding, Benno
    Aktas, Bahriye
    Kuemmel, Sherko
    Reimer, Toralf
    Stefek, Andrea
    Lorenz-Salehi, Fatemeh
    Krabisch, Petra
    Just, Marianne
    Augustin, Doris
    Liedtke, Cornelia
    Chao, Calvin
    Shak, Steven
    Wuerstlein, Rachel
    Kreipe, Hans H.
    Harbeck, Nadia
    BREAST CANCER RESEARCH AND TREATMENT, 2019, 175 (01) : 265 - 266